Krebs Biochemicals & Industries Limited (KREBSBIO) Share Price & AI Investment Analysis

Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applicatio. Track Krebs Biochemicals & Industries Limited's live NSE:KREBSBIO share price ₹57.31 (+3.30%), market cap ₹₹1B. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for KREBSBIO — real-time NSE India stock intelligence.